一个双流深度学习框架用于使用MRI电磁共振检测阿尔茨海默病
Nadia A Mohsin1, Mohammed H Abdul Ameer2
1Department of Computer Science, Faculty of Computer Science and Mathematics, University of Kufa, Najaf 54001, Iraq.
Journal of imaging
|January 27, 2026
概括
这项研究引入了MRI声化来诊断阿尔茨海默病 (AD). 将音频和视觉MRI数据结合起来,显著提高了AD和轻度认知障碍 (MCI) 的诊断准确度.
科学领域:
- 神经学 神经学
- 医疗成像医学成像
- 人工智能的人工智能
背景情况:
- 阿尔茨海默病 (AD) 是一种渐进的脑部疾病,影响全球数以百万计的人,其特点是记忆力丧失和认知能力下降.
- 磁共振成像 (MRI) 是一个关键的诊断工具,但目前的方法主要使用视觉数据,忽略了其他潜在的特征.
- 探索新的方法来提高AD诊断对于早期干预和患者管理至关重要.
研究的目的:
- 调查MRI声定的诊断潜力,作为阿尔茨海默病常规图像方法的补充方法.
- 开发和评估一个新的双流多式联络框架,整合2DMRI片及其音频表示.
主要方法:
- 开发了一种新的双流多式联络框架,将2DMRI切片转化为音频信号,使用加博波和希尔伯特空间填充曲线.
- 该框架分别使用卷积神经网络 (CNN) 和YAMNet处理图像和音频模式.
- 数据融合是通过后勤回归来实现的,以结合两种模式的特征.
主要成果:
- 多式模式框架在区分阿尔茨海默病 (AD) 和认知正常 (CN) 主题 (98.2%) 中取得了很高的准确性.
- 该系统在区分AD与轻度认知障碍 (MCI) (94%) 和MCI与NC受试者 (93.2%) 中表现出强的表现.
结论:
- 磁力共振成像 (MRI) 声化为从成像数据中提取补充诊断信息提供了一个有前途的新途径.
- 这种方法突出了成像数据的音频转换的潜力,用于增强神经系统疾病的特征提取和分类.
- 开发的多式联络框架显示了提高阿尔茨海默病诊断准确性的巨大潜力.
相关概念视频
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...